Novo Nordisk seeks China approval for oral Wegovy drug
Go back to Novo Nordisk seeks China approval for oral Wegovy drug| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1138.28 +22.58 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1115.70 | 52 Week High | $88.16 | |||
| Open | $1142.20 | 52 Week Low | $67.88 | |||
| Day High | $1153.95 | P/E | 263.49 | |||
| Day Low | $1130.50 | EPS | $4.32 | |||
| Volume | 2,166,454 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 43.45 +0.38 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.07 | 52 Week High | $59.00 | |||
| Open | $43.66 | 52 Week Low | $32.80 | |||
| Day High | $43.71 | P/E | N/A | |||
| Day Low | $43.07 | EPS | $0.00 | |||
| Volume | 6,510,661 | |||||
